Sign in to edit your profile (add interests, mentoring, photo, etc.)

    William Tseng, MD

    TitleAssistant Professor of Clinical Surgery
    SchoolKeck School of Medicine of USC
    AddressHCC 1510 San Pablo
    Health Sciences Campus
    Los Angeles California 90033
    vCardDownload vCard

      Collapse Overview 
      Collapse Overview
      William W Tseng, MD is Assistant Professor of Surgery at the Keck School of Medicine at USC. He obtained his undergraduate and medical degrees from Northwestern University, under the Honors Program in Medical Education. He did residency training in General Surgery at the University of California at San Francisco and then completed subspecialty fellowship training in Surgical Oncology at the University of Texas M.D. Anderson Cancer Center.

      Dr. Tseng‘s clinical focus and expertise is in soft tissue sarcoma and melanoma. He has published extensively and won several awards for work done in both of these disease areas. Dr. Tseng’s research interest is in tumor immunology and immunotherapy. He completed dedicated research fellowships in immunology at Stanford University and M.D. Anderson.

      Collapse ORNG Applications 
      Collapse Websites

      Collapse Bibliographic 
      Collapse Publications
      Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
      List All   |   Timeline
      1. Tseng W, Gronchi A. Surgery for recurrence in retroperitoneal leiomyosarcoma: Is it all about selection? J Surg Oncol. 2017 Sep; 116(3):267-268. PMID: 28672078.
        View in: PubMed
      2. In GK, Hu JS, Tseng W. Treatment of advanced, metastatic soft tissue sarcoma: latest evidence and clinical considerations. Ther Adv Med Oncol. 2017 Aug; 9(8):533-550. PMID: 28794805.
        View in: PubMed
      3. Tseng W, Pollock RE, Gronchi A. The Trans-Atlantic Retroperitoneal Sarcoma Working Group (TARPSWG): "Red wine or white"? Ann Surg Oncol. 2016 Dec; 23(13):4418-4420. PMID: 27613555.
        View in: PubMed
      4. Tseng W, Chopra S, Engleman EG, Pollock RE. Hypothesis: The Intratumoral Immune Response against a Cancer Progenitor Cell Impacts the Development of Well-Differentiated versus Dedifferentiated Disease in Liposarcoma. Front Oncol. 2016; 6:134. PMID: 27376027; PMCID: PMC4901033.
      5. Byerly S, Chopra S, Nassif NA, Chen P, Sener SF, Eisenberg BL, Tseng W. The role of margins in extremity soft tissue sarcoma. J Surg Oncol. 2016 Mar; 113(3):333-8. PMID: 26662660.
        View in: PubMed
      6. Olimpiadi Y, Song S, Hu JS, Matcuk GR, Chopra S, Eisenberg BL, Sener SF, Tseng W. Contemporary Management of Retroperitoneal Soft Tissue Sarcomas. Curr Oncol Rep. 2015 Aug; 17(8):39. PMID: 26092408.
        View in: PubMed
      7. Tseng W, Zhou S, To CA, Thall PF, Lazar AJ, Pollock RE, Lin PP, Cormier JN, Lewis VO, Feig BW, Hunt KK, Ballo MT, Patel S, Pisters PW. Phase 1 adaptive dose-finding study of neoadjuvant gemcitabine combined with radiation therapy for patients with high-risk extremity and trunk soft tissue sarcoma. Cancer. 2015 Oct 15; 121(20):3659-67. PMID: 26177983; PMCID: PMC4777348.
      8. Khoury M, Sim GC, Harao M, Radvanyi L, Amini B, Benjamin RS, Pisters PW, Pollock RE, Tseng W. Multicystic dedifferentiated retroperitoneal liposarcoma: tumour cyst fluid analysis and implications for management. BMJ Case Rep. 2015 Jul 08; 2015. PMID: 26156843.
        View in: PubMed
      9. Tseng W, Malu S, Zhang M, Chen J, Sim GC, Wei W, Ingram D, Somaiah N, Lev DC, Pollock RE, Lizée G, Radvanyi L, Hwu P. Analysis of the intratumoral adaptive immune response in well differentiated and dedifferentiated retroperitoneal liposarcoma. Sarcoma. 2015; 2015:547460. PMID: 25705114; PMCID: PMC4326351.
      10. Tseng W, Amini B, Madewell JE. Follow-up of the soft tissue sarcoma patient. J Surg Oncol. 2015 Apr; 111(5):641-5. PMID: 25322963.
        View in: PubMed
      11. Tseng W, Madewell JE, Wei W, Somaiah N, Lazar AJ, Ghadimi MP, Hoffman A, Pisters PW, Lev DC, Pollock RE. Locoregional disease patterns in well-differentiated and dedifferentiated retroperitoneal liposarcoma: implications for the extent of resection? Ann Surg Oncol. 2014 Jul; 21(7):2136-43. PMID: 24705628.
        View in: PubMed
      12. Tseng W, Somaiah N, Engleman EG. Potential for immunotherapy in soft tissue sarcoma. Hum Vaccin Immunother. 2014; 10(11):3117-24. PMID: 25625925; PMCID: PMC4514087.
      13. Tseng W, Somaiah N, Lazar AJ, Lev DC, Pollock RE. Novel systemic therapies in advanced liposarcoma: a review of recent clinical trial results. Cancers (Basel). 2013 May 10; 5(2):529-49. PMID: 24216990; PMCID: PMC3730323.
      14. Tseng W, Demicco EG, Lazar AJ, Lev DC, Pollock RE. Lymphocyte composition and distribution in inflammatory, well-differentiated retroperitoneal liposarcoma: clues to a potential adaptive immune response and therapeutic implications. Am J Surg Pathol. 2012 Jun; 36(6):941-4. PMID: 22446945.
        View in: PubMed
      15. Tseng W, Wang SC, Eichler CM, Warren RS, Nakakura EK. Complete and safe resection of challenging retroperitoneal tumors: anticipation of multi-organ and major vascular resection and use of adjunct procedures. World J Surg Oncol. 2011 Nov 04; 9:143. PMID: 22054416; PMCID: PMC3235074.